Home Other Building Blocks 220991-32-2
220991-32-2,MFCD27966869
Catalog No.:AA00C2TL

220991-32-2 | Robenacoxib

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%
1 week  
$458.00   $320.00
- +
5mg
95%
1 week  
$1,004.00   $703.00
- +
10mg
95%
1 week  
$1,349.00   $944.00
- +
25mg
95%
1 week  
$1,875.00   $1,312.00
- +
50mg
95%
1 week  
$2,320.00   $1,624.00
- +
100mg
95%
1 week  
$2,915.00   $2,040.00
- +
500mg
95%
1 week  
$5,658.00   $3,960.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00C2TL
Chemical Name:
Robenacoxib
CAS Number:
220991-32-2
Molecular Formula:
C16H13F4NO2
Molecular Weight:
327.2735
MDL Number:
MFCD27966869
SMILES:
CCc1ccc(c(c1)CC(=O)O)Nc1c(F)c(F)cc(c1F)F
Properties
Computed Properties
 
Complexity:
398  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  
XLogP3:
4.1  

Literature

Title: Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.

Journal: The Journal of veterinary medical science 20120901

Title: Comparison of oral robenacoxib and ketoprofen for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats: a randomised clinical trial.

Journal: Veterinary journal (London, England : 1997) 20120801

Title: Comparison of injectable robenacoxib versus meloxicam for peri-operative use in cats: results of a randomised clinical trial.

Journal: Veterinary journal (London, England : 1997) 20120701

Title: Safety of oral robenacoxib in the cat.

Journal: Journal of veterinary pharmacology and therapeutics 20120601

Title: Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.

Journal: Journal of veterinary pharmacology and therapeutics 20120401

Title: Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation.

Journal: Journal of veterinary pharmacology and therapeutics 20120201

Title: Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.

Journal: Journal of veterinary pharmacology and therapeutics 20110601

Title: Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs.

Journal: American journal of veterinary research 20110201

Title: Evaluation of the cyclooxygenase selectivity of robenacoxib and its effect on recovery of ischemia-injured jejunal mucosa in horses.

Journal: American journal of veterinary research 20110201

Title: Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.

Journal: Pharmaceutical research 20101201

Title: In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study.

Journal: Journal of veterinary pharmacology and therapeutics 20101001

Title: Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.

Journal: Journal of veterinary pharmacology and therapeutics 20100401

Title: Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.

Journal: Journal of veterinary pharmacology and therapeutics 20090201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 220991-32-2
Tags:220991-32-2 Molecular Formula|220991-32-2 MDL|220991-32-2 SMILES|220991-32-2 Robenacoxib